Lido Advisors, LLC

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1650150 Los Angeles, CA

Back to VRTX Full portfolio

Position in VRTX

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$22,525,214

+$3,095,813 QoQ

Shares Held

45,347

+4.2% QoQ

Ownership

0.018%

of shares outstanding

% of Portfolio

0.14%

of 13F equity value

Holder Rank

#247

of 1,735 holders

Holding Since

Mar 2020

26 quarters on record

Voting authority Sole 59% Shared 0% None 41%

Common Shares in VRTX Over Time

Shares Held

Position Value (USD)

Derivatives in VRTX

reported options exposure · as of Jun 30, 2026

CallValue

CallShares

PutValue

$149,019

PutShares

300

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Lido Advisors, LLC holds $48,509,639 across 38 Biotechnology names. VRTX ranks #1 (46.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma This page	45,347	$22,525,214
2	REGN	Regeneron Pharmaceuticals, Inc.	11,647	$7,262,370
3	INCY	Incyte Corp	18,327	$2,077,548
4	IDYA	IDEAYA Biosciences, Inc.	51,212	$1,908,671
5	RVMD	Revolution Medicines, Inc.	8,476	$1,587,385
6	TARS	Tarsus Pharmaceuticals, Inc.	24,322	$1,530,826
7	RPRX	Royalty Pharma plc	25,158	$1,410,609
8	MRNA	Moderna, Inc.	16,522	$1,157,035

All Filings in VRTX

Export CSV

38 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$149,019	300	0.0%	Put	Sole	2026-08-07
2026-06-30	$22,525,214	45,347	+4.2%	Shares	Defined	2026-08-07
2026-03-31	$133,962	300	0.0%	Put	Sole	2026-05-13
2026-03-31	$19,429,401	43,511	-18.8%	Shares	Defined	2026-05-13
2025-12-31	$136,008	300	0.0%	Put	Sole	2026-02-10
2025-12-31	$24,298,735	53,597	-0.2%	Shares	Defined	2026-02-10
2025-09-30	$117,492	300	0.0%	Put	Sole	2025-11-14
2025-09-30	$21,029,108	53,695	+17.2%	Shares	Sole	2025-11-14
2025-06-30	$20,399,952	45,822	+33.9%	Shares	Defined	2025-08-13
2025-06-30	$133,560	300	-76.9%	Put	Sole	2025-08-13
2025-03-31	$16,596,356	34,232	+8.3%	Shares	Defined	2025-05-15
2025-03-31	$630,266	1,300	0.0%	Put	Sole	2025-05-15
2024-12-31	$12,727,734	31,606	+29.5%	Shares	Defined	2025-02-14
2024-12-31	$523,510	1,300	0.0%	Put	Sole	2025-02-14
2024-09-30	$11,347,486	24,399	+1.4%	Shares	Sole	2024-11-14
2024-09-30	$604,604	1,300	0.0%	Put	Sole	2024-11-14
2024-06-30	$609,336	1,300	-13.3%	Put	Sole	2024-08-15
2024-06-30	$11,279,276	24,064	+2.3%	Shares	Defined	2024-08-15
2024-03-31	$9,837,446	23,534	-0.4%	Shares	Defined	2024-05-15
2024-03-31	$627,015	1,500	0.0%	Put	Sole	2024-05-15
2023-12-31	$9,611,961	23,623	-39.4%	Shares	Defined	2024-02-14
2023-12-31	$610,335	1,500	0.0%	Put	Sole	2024-02-14
2023-09-30	$13,545,515	38,953	+126.6%	Shares	Sole	2023-11-14
2023-09-30	$521,610	1,500	—	Put	Sole	2023-11-14
2023-06-30	$6,050,034	17,192	-29.2%	Shares	Sole	2023-08-09
2023-03-31	$7,649,583	24,279	-14.0%	Shares	Defined	2023-05-15
2022-12-31	$8,152,836	28,232	+76.5%	Shares	Sole	2023-02-14
2022-09-30	$4,632,060	15,998	+285.8%	Shares	Defined	2022-11-14
2022-06-30	$1,168,583	4,147	+2.3%	Shares	Sole	2022-08-15
2022-03-31	$1,058,233	4,055	+21.3%	Shares	Sole	2022-05-17
2021-12-31	$734,122	3,343	+43.5%	Shares	Sole	2022-02-15
2021-09-30	$422,638	2,330	+14.5%	Shares	Sole	2022-02-15
2021-06-30	$410,317	2,035	+11.9%	Shares	Sole	2021-08-12
2021-03-31	$390,884	1,819	-6.7%	Shares	Sole	2021-05-13
2020-12-31	$460,626	1,949	+7.1%	Shares	Sole	2021-02-08
2020-09-30	$494,986	1,819	+13.1%	Shares	Sole	2020-11-12
2020-06-30	$466,818	1,608	+8.6%	Shares	Sole	2020-08-12
2020-03-31	$352,166	1,480	—	Shares	Sole	2020-05-13
No filing history on record for this holder in this stock.